{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:32:37Z","timestamp":1770881557283,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13048-018-0476-y","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T02:21:33Z","timestamp":1547086893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recurrent ovarian mixed germ cell tumor with unusual malignant transformation: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Yi-Le","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Ru","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shyen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"issue":"2","key":"476_CR1","first-page":"200","volume":"64","author":"DM Gershenson","year":"1984","unstructured":"Gershenson DM, Del Junco G, Copeland LJ, Rutledge FN. Mixed germ cell tumors of the ovary. Obstet Gynecol. 1984;64(2):200\u20136.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"476_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/01.AOG.0000216004.22588.ce","volume":"107","author":"HO Smith","year":"2006","unstructured":"Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107(5):1075\u201385.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"476_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.308.5.516","volume":"308","author":"RT Burkman","year":"2012","unstructured":"Burkman RT. Berek & Novak\u2019s gynecology. JAMA. 2012;308(5):516\u20137.","journal-title":"JAMA"},{"issue":"4","key":"476_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00004347-199410000-00001","volume":"13","author":"DM O'Connor","year":"1994","unstructured":"O'Connor DM, Norris HJ. The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int j Gynecol Pathol. 1994;13(4):283\u20139.","journal-title":"Int j Gynecol Pathol"},{"issue":"5","key":"476_CR5","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/1097-0142(197605)37:5<2359::AID-CNCR2820370528>3.0.CO;2-Q","volume":"37","author":"HJ Norris","year":"1976","unstructured":"Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer. 1976;37(5):2359\u201372.","journal-title":"Cancer"},{"key":"476_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/cncr.29732","volume":"122","author":"F Pashankar","year":"2016","unstructured":"Erratum, Pashankar F, Hale JP, Dang H, et al. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. 2016;122:230\u20137 Cancer. 2018;124(6):1302.","journal-title":"Cancer"},{"issue":"1","key":"476_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ygyno.2011.06.037","volume":"123","author":"D Vicus","year":"2011","unstructured":"Vicus D, Beiner ME, Clarke B, Klachook S, Le LW, Laframboise S, et al. Ovarian immature teratoma: treatment and outcome in a single institutional cohort. Gynecol Oncol. 2011;123(1):50\u20133.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"476_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ctrv.2008.02.002","volume":"34","author":"D Pectasides","year":"2008","unstructured":"Pectasides D, Pectasides E, Kassanos D. Germ cell tumors of the ovary. Cancer Treat Rev. 2008;34(5):427\u201341.","journal-title":"Cancer Treat Rev"},{"issue":"20","key":"476_CR9","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2007.10.8738","volume":"25","author":"DM Gershenson","year":"2007","unstructured":"Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol. 2007;25(20):2938\u201343.","journal-title":"J Clin Oncol"},{"issue":"30","key":"476_CR10","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1200\/JCO.2006.06.2489","volume":"24","author":"N Murugaesu","year":"2006","unstructured":"Murugaesu N, Schmid P, Dancey G, Agarwal R, Holden L, McNeish I, et al. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol. 2006;24(30):4862\u20136.","journal-title":"J Clin Oncol"},{"issue":"5","key":"476_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/01.cco.0000239891.44031.38","volume":"18","author":"DM Patterson","year":"2006","unstructured":"Patterson DM, Rustin GJ. Controversies in the management of germ cell tumours of the ovary. Curr Opin Oncol. 2006;18(5):500\u20136.","journal-title":"Curr Opin Oncol"},{"issue":"Suppl 2","key":"476_CR12","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1038\/modpathol.3800310","volume":"18","author":"TM Ulbright","year":"2005","unstructured":"Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18(Suppl 2):S61\u201379.","journal-title":"Mod Pathol"},{"issue":"5","key":"476_CR13","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/0002-9378(68)90384-0","volume":"102","author":"JD Woodruff","year":"1968","unstructured":"Woodruff JD, Protos P, Peterson WF. Ovarian teratomas. Relationship of histologic and ontogenic factors to prognosis. Am J Obstet Gynecol. 1968;102(5):702\u201315.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"476_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ygyno.2007.02.032","volume":"105","author":"J Li","year":"2007","unstructured":"Li J, Yang W, Wu X. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Gynecol Oncol. 2007;105(3):769\u201375.","journal-title":"Gynecol Oncol"},{"key":"476_CR15","first-page":"97","volume":"4","author":"J Bouquet de Joliniere","year":"2014","unstructured":"Bouquet de Joliniere J, Ben Ali N, Fadhlaoui A, Dubuisson JB, Guillou L, Sutter A, et al. Two case reports of a malignant germ cell tumor of ovary and a granulosa cell tumor: interest of tumoral immunochemistry in the identification and management. Front Oncol. 2014;4:97.","journal-title":"Front Oncol"},{"key":"476_CR16","doi-asserted-by":"crossref","unstructured":"Matei D, Brown J, Frazier L. Updates in the management of ovarian germ cell tumors. Am Soc Clin Oncol Educ Book. 2013:e210-e216.","DOI":"10.1200\/EdBook_AM.2013.33.e210"},{"issue":"3","key":"476_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00004347-198709000-00002","volume":"6","author":"I Yanai-Inbar","year":"1987","unstructured":"Yanai-Inbar I, Scully RE. Relation of ovarian dermoid cysts and immature teratomas: an analysis of 350 cases of immature teratoma and 10 cases of dermoid cyst with microscopic foci of immature tissue. Int J Gynecol Pathol. 1987;6(3):203\u201312.","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"476_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ygyno.2004.11.035","volume":"96","author":"Y Rezk","year":"2005","unstructured":"Rezk Y, Sheinfeld J, Chi DS. Prolonged survival following salvage surgery for chemorefractory ovarian immature teratoma: a case report and review of the literature. Gynecol Oncol. 2005;96(3):883\u20137.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"476_CR19","first-page":"346","volume":"49","author":"PJ DiSaia","year":"1977","unstructured":"DiSaia PJ, Saltz A, Kagan AR, Morrow CP. Chemotherapeutic retroconversion of immature teratoma of the ovary. Obstet Gynecol. 1977;49(3):346\u201350.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"476_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/gyno.1994.1280","volume":"55","author":"A Munkarah","year":"1994","unstructured":"Munkarah A, Gershenson DM, Levenback C, Silva EG, Messing MJ, Morris M, et al. Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol. 1994;55(2):217\u201323.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"476_CR21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1006\/gyno.2001.6541","volume":"84","author":"YB David","year":"2002","unstructured":"David YB, Weiss A, Shechtman L, Shalev E. Tumor chemoconversion following surgery, chemotherapy, and normalization of serum tumor markers in a woman with a mixed type germ cell ovarian tumor. Gynecol Oncol. 2002;84(3):464\u20137.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"476_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002647","volume":"95","author":"S Li","year":"2016","unstructured":"Li S, Liu Z, Dong C, Long F, Liu Q, Sun D, et al. Growing Teratoma syndrome secondary to ovarian Giant immature Teratoma in an adolescent girl: a case report and literature review. Medicine. 2016;95(7):e2647.","journal-title":"Medicine"},{"issue":"1","key":"476_CR23","first-page":"22","volume":"84","author":"JT Comerci Jr","year":"1994","unstructured":"Comerci JT Jr, Licciardi F, Bergh PA, Gregori C, Breen JL. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol. 1994;84(1):22\u20138.","journal-title":"Obstet Gynecol"},{"issue":"12","key":"476_CR24","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S1470-2045(08)70306-1","volume":"9","author":"A Hackethal","year":"2008","unstructured":"Hackethal A, Brueggmann D, Bohlmann MK, Franke FE, Tinneberg HR, Munstedt K. Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data. Lancet Oncol. 2008;9(12):1173\u201380.","journal-title":"Lancet Oncol"},{"issue":"3","key":"476_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/1097-0142(19870201)59:3<533::AID-CNCR2820590329>3.0.CO;2-X","volume":"59","author":"DD Davey","year":"1987","unstructured":"Davey DD, Ulbright TM, Loehrer PJ, Einhorn LH, Donohue JP, Williams SD. The significance of atypia within teratomatous metastases after chemotherapy for malignant germ cell tumors. Cancer. 1987;59(3):533\u20139.","journal-title":"Cancer"},{"issue":"3","key":"476_CR26","first-page":"672","volume":"49","author":"SM Castedo","year":"1989","unstructured":"Castedo SM, de Jong B, Oosterhuis JW, Idenburg VJ, Seruca R, Buist J, et al. Chromosomal changes in mature residual teratomas following polychemotherapy. Cancer Res. 1989;49(3):672\u20136.","journal-title":"Cancer Res"},{"issue":"2","key":"476_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/1097-0142(19860715)58:2<264::AID-CNCR2820580211>3.0.CO;2-P","volume":"58","author":"WM Molenaar","year":"1986","unstructured":"Molenaar WM, Oosterhuis JW, Meiring A, Sleyfer DT, Schraffordt Koops H, Cornelisse CJ. Histology and DNA contents of a secondary malignancy arising in a mature residual lesion six years after chemotherapy for a disseminated nonseminomatous testicular tumor. Cancer. 1986;58(2):264\u20138.","journal-title":"Cancer"},{"issue":"4","key":"476_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00004347-199610000-00009","volume":"15","author":"GL Davis","year":"1996","unstructured":"Davis GL. Malignant melanoma arising in mature ovarian cystic teratoma (dermoid cyst). Report of two cases and literature analysis. Int J Gynecol Pathol. 1996;15(4):356\u201362.","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"476_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/gyn.2014.0115","volume":"31","author":"H Narendra","year":"2015","unstructured":"Narendra H, Manilal B, Revanth G, Praveen CS, Radhika K, Asha T. Metastasizing primary malignant melanoma of the ovary: a diagnostic enigma. J Gynecol Surg. 2015;31(3):166\u201372.","journal-title":"J Gynecol Surg"},{"issue":"3","key":"476_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0090-8258(81)90139-6","volume":"12","author":"HS Cronje","year":"1981","unstructured":"Cronje HS, Woodruff JD. Primary ovarian malignant melanoma arising in cystic teratoma. Gynecol Oncol. 1981;12(3):379\u201383.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"476_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5468\/ogs.2013.56.3.201","volume":"56","author":"HS Hyun","year":"2013","unstructured":"Hyun HS, Mun ST. Primary malignant melanoma arising in a cystic teratoma. Obstet Gynecol Sci. 2013;56(3):201\u20134.","journal-title":"Obstet Gynecol Sci"},{"issue":"6","key":"476_CR32","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/modpathol.3800596","volume":"19","author":"C Poulos","year":"2006","unstructured":"Poulos C, Cheng L, Zhang S, Gersell DJ, Ulbright TM. Analysis of ovarian teratomas for isochromosome 12p: evidence supporting a dual histogenetic pathway for teratomatous elements. Mod Pathol. 2006;19(6):766\u201371.","journal-title":"Mod Pathol"},{"issue":"6","key":"476_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","volume":"204","author":"R Salani","year":"2011","unstructured":"Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, et al. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011;204(6):466\u201378.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"476_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.cco.0000432609.39293.77","volume":"25","author":"I Vazquez","year":"2013","unstructured":"Vazquez I, Rustin GJ. Current controversies in the management of germ cell ovarian tumours. Curr Opin Oncol. 2013;25(5):539\u201345.","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"476_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMoa067749","volume":"357","author":"LH Einhorn","year":"2007","unstructured":"Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med. 2007;357(4):340\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"476_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.juro.2012.10.091","volume":"189","author":"JP Richie","year":"2013","unstructured":"Richie JP. Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian urologic oncology group\/German testicular cancer study group cooperative study. J Urol. 2013;189(2):533\u20134.","journal-title":"J Urol"},{"issue":"5","key":"476_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/COC.0b013e31827de90d","volume":"37","author":"A Jain","year":"2014","unstructured":"Jain A, Brames MJ, Vaughn DJ, Einhorn LH. Phase II clinical trial of oxaliplatin and bevacizumab in refractory germ cell tumors. Am J Clin Oncol. 2014;37(5):450\u20133.","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"476_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1210\/er.2012-1045","volume":"34","author":"SM Kraggerud","year":"2013","unstructured":"Kraggerud SM, Hoei-Hansen CE, Alagaratnam S, Skotheim RI, Abeler VM, Rajpert-De Meyts E, et al. Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis. Endocr Rev. 2013;34(3):339\u201376.","journal-title":"Endocr Rev"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-018-0476-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-018-0476-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-018-0476-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T19:09:20Z","timestamp":1578596960000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-018-0476-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1186\/s13048-018-0476-y","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work has been approved by the ethics committee of Taipei Veterans General Hospital, and informed consent for publication was obtained from the patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient and publication of this report and accompanying images. A copy of this written consent is available for review by the Editor-in Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"2"}}